These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21156770)

  • 1. Effects of a highly selective acetylcholine-activated K+ channel blocker on experimental atrial fibrillation.
    Machida T; Hashimoto N; Kuwahara I; Ogino Y; Matsuura J; Yamamoto W; Itano Y; Zamma A; Matsumoto R; Kamon J; Kobayashi T; Ishiwata N; Yamashita T; Ogura T; Nakaya H
    Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):94-102. PubMed ID: 21156770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of the muscarinic potassium current by KB130015, a new antiarrhythmic agent to treat atrial fibrillation].
    Borchard R; van Bracht M; Wickenbrock I; Prull MW; Pott L; Trappe HJ
    Med Klin (Munich); 2005 Nov; 100(11):697-703. PubMed ID: 16328176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Perspectives and limitations in the treatment of vagus-induced atrial fibrillation. Insights from cellular pharmacology].
    Brandts B; Van Bracht M; Dirkmann D; Borchard R; Wickenbrock I; Prull MW; Meine M; Trappe HJ
    Med Klin (Munich); 2004 Jul; 99(7):341-6. PubMed ID: 15322712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological characterization and antiarrhythmic efficacy of the mixed potassium channel-blocking antiarrhythmic agent AZ13395438 in vitro and in vivo.
    Jacobson I; Duker G; Florentzson M; Linhardt G; Lindhardt E; Nordkam AK; Åstrand A; Carlsson L
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):290-300. PubMed ID: 23307834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of in vivo and in vitro electrophysiological and antiarrhythmic effects of a novel IKACh blocker, NIP-151: a comparison with an IKr-blocker dofetilide.
    Hashimoto N; Yamashita T; Tsuruzoe N
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):162-9. PubMed ID: 18287884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of cardiac potassium channels.
    Li GR; Dong MQ
    Adv Pharmacol; 2010; 59():93-134. PubMed ID: 20933200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium Channel Blockade Enhances Atrial Fibrillation-Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade.
    Aguilar M; Xiong F; Qi XY; Comtois P; Nattel S
    Circulation; 2015 Dec; 132(23):2203-11. PubMed ID: 26499964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of I
    Juhász V; Hornyik T; Benák A; Nagy N; Husti Z; Pap R; Sághy L; Virág L; Varró A; Baczkó I
    Can J Physiol Pharmacol; 2018 Jan; 96(1):18-25. PubMed ID: 28892643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential densities of muscarinic acetylcholine receptor and I(K,ACh) in canine supraventricular tissues and the effect of amiodarone on cholinergic atrial fibrillation and I(K,ACh).
    Huang CX; Zhao QY; Liang JJ; Chen H; Yang B; Jiang H; Li GS
    Cardiology; 2006; 106(1):36-43. PubMed ID: 16612067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial-selective K
    Ravens U
    Can J Physiol Pharmacol; 2017 Nov; 95(11):1313-1318. PubMed ID: 28738160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of selective acetylcholine-sensitive K+ -channel blockade as a therapeutic strategy for atrial fibrillation].
    Hashimoto N
    Nihon Yakurigaku Zasshi; 2010 Aug; 136(2):77-82. PubMed ID: 20702965
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of the selective KACh channel blocker NTC-801 on atrial fibrillation in a canine model of atrial tachypacing: comparison with class Ic and III drugs.
    Yamamoto W; Hashimoto N; Matsuura J; Machida T; Ogino Y; Kobayashi T; Yamanaka Y; Ishiwata N; Yamashita T; Tanimoto K; Miyoshi S; Fukuda K; Nakaya H; Ogawa S
    J Cardiovasc Pharmacol; 2014 May; 63(5):421-7. PubMed ID: 24805146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of small-conductance Ca2+-activated K+ channels terminates and protects against atrial fibrillation.
    Diness JG; Sørensen US; Nissen JD; Al-Shahib B; Jespersen T; Grunnet M; Hansen RS
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):380-90. PubMed ID: 20562443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of amiodarone on the muscarinic acetylcholine receptor-operated potassium current in guinea pig atrial cells.
    Watanabe Y; Hara Y; Tamagawa M; Nakaya H
    J Pharmacol Exp Ther; 1996 Nov; 279(2):617-24. PubMed ID: 8930164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic Mechanisms of SK Channel Inhibition in the Rat Atrium.
    Skibsbye L; Wang X; Axelsen LN; Bomholtz SH; Nielsen MS; Grunnet M; Bentzen BH; Jespersen T
    J Cardiovasc Pharmacol; 2015 Aug; 66(2):165-76. PubMed ID: 25856531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs.
    Li GR; Wang HB; Qin GW; Jin MW; Tang Q; Sun HY; Du XL; Deng XL; Zhang XH; Chen JB; Chen L; Xu XH; Cheng LC; Chiu SW; Tse HF; Vanhoutte PM; Lau CP
    Circulation; 2008 May; 117(19):2449-57. PubMed ID: 18458165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
    Lagrutta A; Wang J; Fermini B; Salata JJ
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrillatory agents and potassium channels in the atria: pore block versus channel trafficking.
    McEwen DP; Martens JR
    Mol Interv; 2009 Apr; 9(2):79-86. PubMed ID: 19401540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Termination of aconitine-induced atrial fibrillation by the KACh-channel blocker tertiapin: underlying electrophysiological mechanism.
    Suzuki K; Matsumoto A; Nishida H; Reien Y; Maruyama H; Nakaya H
    J Pharmacol Sci; 2014; 125(4):406-14. PubMed ID: 25030741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can inhibition of IKur promote atrial fibrillation?
    Burashnikov A; Antzelevitch C
    Heart Rhythm; 2008 Sep; 5(9):1304-9. PubMed ID: 18774108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.